Loading...
Docoh

Aziyo Biologics (AZYO)

Employees
Data from SEC filings
Employee count
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On June 7, 2021, Aziyo Biologics, Inc. (the “Company”) held its annual meeting of stockholders. A total of 5,998,231 shares of the Company’s Class A common stock were present in person or represented by proxy at the meeting, representing approximately 84.56% of the Company’s common stock outstanding as of the April 13, 2021 record date. Following are the voting results for the proposals considered and voted upon at the meeting, each of which were described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 23, 2021.